Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.

<h4>Background and aims</h4>The present study aimed to report our real-life experience of the TPO receptor agonist lusutrombopag for cirrhotic patients with low platelet counts.<h4>Methods</h4>We studied platelet counts in 1,760 cirrhotic patients undergoing invasive procedur...

Full description

Bibliographic Details
Main Authors: Hitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, Yuka Takahashi, Jun Itakura, Kaoru Tsuchiya, Yutaka Yasui, Nobuharu Tamaki, Kenta Takaura, Yasuyuki Komiyama, Mayu Higuchi, Youhei Kubota, Wann Wang, Mao Okada, Takao Shimizu, Keiya Watakabe, Nobuyuki Enomoto, Namiki Izumi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0211122